Progress Toward Healthy People 2020: CDC Report Claims Reduction in Cancer Incidence
December 18th 2015Results of an analysis of 2012 cancer incidence and survival from various cancer registries, published in CDC's Morbidity and Mortality Weekly Report, indicates reduced incidence of overall cancer across the United States.
Read More
Need to Lower Drug Costs, Not the Size of the Donut Hole, for Medicare Beneficiaries With Cancer
December 17th 2015A study in the Journal of Clinical Oncology predicts financial stress on Medicare Part D beneficiaries on oral anticancer medicines, even after the expected closing of the donut hole in 2020.
Read More
NCCS Responds to CMS, Demands Flexibility With Alternative Payment Models
December 11th 2015The National Coalition for Cancer Survivorship has submitted comments to CMS, providing feedback on the Merit-Based Incentive Payment System and Alternative Payment Models proposed by CMS as it transitions toward value-based reimbursement.
Read More
ACS/ASCO Offer Guidelines for Primary Care Clinicians Caring for Survivors of Breast Cancer
December 9th 2015The workgroup that generated the guideline included experts in primary care, gynecology, surgical oncology, medical oncology, radiation oncology, and nursing, along with a cancer survivor who provided a patient perspective.
Read More
Abundant Optimism at the ASH/FDA Joint Symposium on New Drug Approvals in Multiple Myeloma
December 8th 2015Primary clinical reviewers from the FDA and 2 clinician experts provided their unique perspectives on the safety, efficacy, and potential for clinical integration of 3 recently approved agents for multiple myeloma: daratumumab (Darzalex), ixazomib (Ninlaro), and elotuzumab (Empliciti).
Read More
Study Shows Academic Hospitals More Adept at Caring for ALL Patients
December 7th 2015During a health outcomes session on the second day of the American Society of Hematology meeting, data presented from a study conducted at the University of Nebraska Medical Center suggested that the site of care bears a significant influence on the outcomes of patients with acute lymphoblastic leukemia.
Read More
Importance of Patient-Reported Outcomes and Quality-of-Life Measures in Myeloid Disease
December 6th 2015Two posters presented at the annual meeting of the American Society of Hematology discussed patient-reported outcomes measures and quality-of-life indicators as supportive tools for treatment in individuals being treated for acute myeloid leukemia and myelodysplastic syndrome.
Read More
How Do You Develop, and Successfully Incorporate, PROs in Hematology? Experts Chime in at ASH
December 6th 2015Presenters at an education session, titled Patient-Reported Outcomes in Hematology, addressed the importance of embracing the patient perspective in healthcare delivery, on the second day of the annual meeting of the American Society of Hematology, being held December 5-8, in Orlando, Florida.
Read More
Experts Share Concepts of Quality Measures and Pay-for-Performance at the Annual ASH Meeting
December 5th 2015At the annual meeting of the American Society of Hematology, providers brooded over implications of quality measures and how they will influence clinical practice in the coming years.
Read More
New Hematology Drugs: Progress and Challenges Discussed at the 57th ASH Meeting
December 5th 2015An early session on the first day of the annual meeting and exposition of the American Society of Hematology, being held December 5-8, 2015, in Orlando, Florida, saw presentations on the promise of newly approved hematology/oncology agents, in addition to the challenges that clinicians face in treating patients with these drugs.
Read More
5 Things to Look for at the Annual Meeting of the American Society of Hematology
December 4th 2015As the annual meeting of the American Society of Hematology kicks off on Saturday, December 5, 2015, a lot of new clinical data will be presented, practice-changing treatments will be introduced, and new healthcare policies will be discussed.
Read More
What Is the True Financial Impact of Prescription Medications? Advera Health Explains
December 3rd 2015In a study published in the Journal of Managed Care & Specialty Pharmacy, the authors present a rating system that includes downstream costs following treatment to estimate the real-world financial impact of the drug.
Read More
Antidepressant Use Safe for Stress in Breast Cancer, Says Kaiser Study
December 2nd 2015An exhaustive study published by Kaiser Permanente in the Journal of the National Cancer Institute has confirmed that antidepressants do not cause recurrence in breast cancer patients treated with tamoxifen.
Read More